US Stock Market Summary - May 15, 2025 | Dow, S&P 500, Nasdaq Updates The US stock market saw a mixed performance on May 15, 2025 , with the Dow Jones slipping while the Nasdaq and S&P 500 managed to notch modest gains. The market reacted to a mix of corporate earnings reports, regulatory developments, and cautious investor sentiment ahead of key economic data. 📈 Major Indices Performance Dow Jones Industrial Average : −89.37 points (−0.21%) to 42,051.06 S&P 500 : +6.03 points (+0.10%) to 5,892.58 Nasdaq Composite : +136.72 points (+0.72%) to 19,146.81 💡 Key Market Drivers Cisco Systems (CSCO) rallied over 5% after issuing a strong earnings forecast and upbeat forward guidance, boosting tech sentiment. UnitedHealth Group (UNH) plunged more than 5% following news of a Department of Justice criminal investigation into its billing practices involving Medicare Advantage claims. Walmart (WMT) shares ...
Johnson & Johnson (JNJ) | S&P 500 Company Analysis Johnson & Johnson (JNJ) , headquartered in New Brunswick, New Jersey, is one of the most iconic and enduring names in global healthcare. Founded in 1886, the company has continuously adapted through relentless innovation, diversification, and a steadfast commitment to improving human health across pharmaceuticals, medical devices, and consumer health products. 1. Business Model: Three Strong Pillars of Healthcare Excellence Before the Kenvue spin-off in 2023, Johnson & Johnson operated through three main segments: Pharmaceuticals: Focused on immunology, oncology, neuroscience, infectious diseases, and vaccines. Medical Devices: Surgical systems, orthopedics, cardiovascular devices, and vision care. Consumer Health (now Kenvue): Household brands like Tylenol, Neutrogena, Listerine, and Band-Aid. Post-spin-off, J&J is now even more focu...